Muestra la distribución de disciplinas para esta publicación.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Indexado |
|
||
| DOI | |||
| Año | 2019 | ||
| Tipo |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Introduction: Mycoplasma pneumoniae is a pathogen know as to the main causal agent of atypical pneumonia, as well as to generate different extrapulmonary sickness, especially in neurological ways, directing to the nervous system, thanks to all its different mechanisms, like: virulence, mimetysm and immunomodulation in to the host. Producing, pathologies like neuropathies, polyneuropathies, encephalopathies, Guillain Barré Syndrome. Objetives: To highlight in the pediatric area, the need to modificate diagnosis criteria and incorporate Guillain-Barre Syndrome clinicals variants, also instruments to diagnosis of neuropathic pathologies. Case presentation: Male patient, 9 years, 8 months old, who consulted in repeated occasions for: dyspepsia, diarrhea and constipation episodes and fiber. Confirmed according to consultation: dysbiosis, common cold, and finally, atypical pneumonia by Mycoplasma Pneumoniae. The patient evolves with: muscular weakness, hyperalgesia and allodynia of upper and inferior extremities. Then, the Neurologist, indicates neurophysiological exams (nerve conduction velocity, evoked potentials, discarding an electromyography, due to hyperalgesia). Diagnosing an axonal polyneuropathy. Which was characterized to present some same aspects, from clinical course of Guillain-Barre Syndrome. Highlighting that the clinical evolution, as also, the syndrome clinical variants, has it a course in adults, characterized by a different beginning and signs, than in children. Retarding and do a wrong diagnosis in pediatric patients. Conclusion: Lack of new diagnosis criteria, the amplitude of these and tools of approach to give a fast and effective diagnosis, and contribute to the optimal recovery of the patient.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Merino, Claudia Zemelman | Mujer |
Universidad San Sebastián - Chile
|
| 2 | Toledo, Ana Petermann | Mujer |
Universidad San Sebastián - Chile
|
| 3 | Petermanntoledo, Daniela | Mujer |
Universidad San Sebastián - Chile
|
| Agradecimiento |
|---|
| 1. Merida-Vieyra J, Aquino-Andrade A, Ribas-Aparicio RM, De Colsa-Ranero A. Cambiando los paradigmas de la infección por M. pneumoniae en pediatría. Acta Pediatr Mex. 2017;38(6):412-26. 2. Waites KB, Balish MF, Atkinson TP. New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections. Future Microbiol. 2008;3:635-48. 3. Inostroza Pinto R. Neumonía por agentes atípicos en niños. Rev Clin Condes. 2017;28(1):90-6. 4. Hopp E, Martínez L, Diaz M. Neumonía por Mycoplasma pneumoniae complicada con pancreatitis y hepatitis aguda: a propósito de un caso. Revista GEN. 2013;67(2):106-10. 5. Waites K,Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697-728. 6. Saraya T. Mycoplasma pneumoniae infection: Basics. J Gen Fam Med. 2017;18:118-25. 7. Baharat B, Venkatram S, Díaz-Fuentes G. Mycoplasma pneumoniae: A Potencially Severe Infection. J Clin Med Res. 2018;10(7): 535-44. 8. Mayo Foundation for Medical Education and Research: Mayo Clinic Staff (2017). The Foundation; ©1998-2018; actualizado 09/08/2017, acceso: 22/09/2018. Disponible en: https://www.mayoclinic.org/diseases-conditions/peripheral-neuropathy/symptoms- |